Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin after ACL reconstruction to reduce hamstring contracture and cyclops syndrome
2020-005742-42Phase 3Active
- Sponsor
- Ramsay Santé
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in Cyclopia and Arthrofibrosis (2 arms), sponsored by Ramsay Santé. Primary endpoint: Knee mobility at Month 2 after botulinum toxin injection. Started Jun 2021; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
CyclopiaArthrofibrosis
Beyond the preview
Go deeper on 2020-005742-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005742-42.